J. Goldman & CO LP Regeneron Pharmaceuticals, Inc. Call Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $20.5 Million - $23.3 Million
-26,400 Reduced 83.02%
5,400 $4.74 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $9.83 Million - $12 Million
14,200 Added 80.68%
31,800 $26.2 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $12.3 Million - $14.6 Million
17,600 New
17,600 $12.6 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $7.46 Million - $9.42 Million
13,000 New
13,000 $8.96 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email